ProPublica spent 14 months investigating how the Food and Drug Administration regulates foreign drugmakers. We found a system ...
Two new Java Cards reproduce the applet lifecycle and expose a T=0 transport bug. Hardware results, CPLC serials, regression tests, and remaining limits.f ...
Forecasts call for Teva's branded drug portfolio to bring it $3.7 billion in revenue next year. At the same time, as it pivots toward high-margin drug products, Teva continues to reduce debt and ...
Teva Pharmaceuticals (NYSE: TEVA) recently hit a new 52-week high of $40.79 per share and has surged 110% in the last year. It's the drugmaker's turnaround, fueled by a pivot from generic to branded ...
Did you pay for a generic prescription drug between May 2009 and December 2019? If so, you may be eligible to receive money from settlements involving some generic drug manufacturers. The Pennsylvania ...
If you take a patented, brand-name medication — a cancer biologic, an autoimmune drug, a specialty injection — the supply chain behind that drug is about to be permanently restructured, starting at 12 ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
અમેરિકા દ્વારા 2029 સુધીમાં આયાતી જેનરિક દવાઓ પર **100-200%** સુધીના ટેરિફની દરખાસ્ત ભારતીય ફાર્મા કંપનીઓ ...
Proposed US tariffs of 100-200% on imported generic medicines by 2029 could affect Indian pharmaceutical giants. Investors are evaluating the potential impact on revenue, profit margins, and the ...
The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results